Target intelligence / Profile preview

BCL2 interacting protein 3 (BNIP3)

Target
BNIP3
Molecular classification
BCL-2 family protein, BH3-only protein, Mitochondrial protein, Other
01

Overview

BNIP3 (BCL2 interacting protein 3) is a member of the BCL-2 protein family that contains a BH3 domain essential for protein-protein interactions with other BCL-2 family members. The protein functions primarily at mitochondrial membranes where it regulates cell death pathways through direct binding interactions that can influence mitochondrial outer membrane permeabilization. BNIP3 acts as a BH3-only protein capable of binding to and inactivating anti-apoptotic BCL-2 proteins, thereby promoting apoptotic cell death under certain cellular conditions. Beyond its role in apoptosis, BNIP3 serves a critical function in regulating mitophagy (mitochondrial autophagy), which is essential for the induction and maintenance of cellular pluripotency. The protein represents a potential therapeutic target due to its involvement in both cell death regulation and cellular reprogramming processes, though specific drug interactions and clinical applications require further investigation.

Other names
BNIP3BCL2 interacting protein 3
02

Mechanism of action

BH3 domain-mediated protein-protein interaction, Mitophagy regulation, Apoptosis modulation

03

Biological functions

ApoptosisCell deathSignal transductionOther
04

Disease associations

CancerOther

Beyond the preview

Go deeper on BCL2 interacting protein 3 (BNIP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 (BNIP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call